Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0225
0.00 (0.00%)
Sep 26, 2024, 11:00 AM EDT

Oncotelic Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Net Income
-1.24-7.95.09-9.39-9.5-6.64
Upgrade
Depreciation & Amortization
--0.010.060.360.06
Upgrade
Other Amortization
0.150.31.981.451.320.75
Upgrade
Asset Writedown & Restructuring Costs
-6.08-12.84---
Upgrade
Loss (Gain) From Sale of Investments
-0.01-0.01---1.77
Upgrade
Stock-Based Compensation
--0.91.182.150.76
Upgrade
Provision & Write-off of Bad Debts
00----
Upgrade
Other Operating Activities
0.070.32.61.952.32-0.07
Upgrade
Change in Accounts Payable
-0.06-0.050.80.220.471.17
Upgrade
Change in Other Net Operating Assets
-0.02-0.04-00.080.07-0.08
Upgrade
Operating Cash Flow
-1.11-1.32-1.45-4.43-2.81-2.28
Upgrade
Cash Acquisitions
-----0.19
Upgrade
Investing Cash Flow
-----0.19
Upgrade
Short-Term Debt Issued
-1.410.973.070.352.09
Upgrade
Total Debt Issued
1.121.410.973.070.352.09
Upgrade
Short-Term Debt Repaid
--0.04--0.5-0.05-
Upgrade
Total Debt Repaid
-0.04-0.04--0.5-0.05-
Upgrade
Net Debt Issued (Repaid)
1.081.380.972.560.32.09
Upgrade
Issuance of Common Stock
--0.161.972.930.08
Upgrade
Other Financing Activities
-0.08-0.13----
Upgrade
Financing Cash Flow
1.011.251.134.533.222.17
Upgrade
Net Cash Flow
-0.11-0.07-0.330.090.410.08
Upgrade
Free Cash Flow
-1.11-1.32-1.45-4.43-2.81-2.28
Upgrade
Free Cash Flow Margin
-1592.37%-1887.21%---161.53%-
Upgrade
Free Cash Flow Per Share
-0.00-0.00-0.00-0.01-0.03-0.04
Upgrade
Cash Interest Paid
0.380.390.40.30.05-
Upgrade
Cash Income Tax Paid
----0-
Upgrade
Levered Free Cash Flow
-0.75-0.58-3.27-4.24-1.43.75
Upgrade
Unlevered Free Cash Flow
-0.37-0.23-3.39-4.44-1.473.47
Upgrade
Change in Net Working Capital
0.14-0.120.8-0.02-0.76-5.35
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.